{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:56:19Z","timestamp":1792065379433,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bcp.2015.10.011","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T16:25:10Z","timestamp":1445790310000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data"],"prefix":"10.1016","volume":"101","author":[{"given":"Lisa A.","family":"Stott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2900-828X","authenticated-orcid":false,"given":"Nicholas D.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.10.011_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tips.2006.01.008","article-title":"The quantitative analysis of drug\u2013receptor interactions: a short history","volume":"27","author":"Colquhoun","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1113\/jphysiol.1909.sp001344","article-title":"The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients","volume":"39","author":"Hill","year":"1909","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1476-5381.1956.tb00006.x","article-title":"A modification of receptor theory","volume":"11","author":"Stephenson","year":"1956","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.bcp.2015.10.011_bib0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.bjp.0702164","article-title":"Binding, gating, affinity and efficacy: the interpretation of structure\u2013activity relationships for agonists and of the effects of mutating receptors","volume":"125","author":"Colquhoun","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1098\/rspb.1957.0018","article-title":"Interaction at end-plate receptors between different choline derivatives","volume":"146","author":"Del Castillo","year":"1957","journal-title":"Proc. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","article-title":"Allosteric modulation of G protein-coupled receptors: a pharmacological perspective","volume":"60","author":"Keov","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.10.011_bib0040","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1476-5381.2011.01749.x","article-title":"Biased signalling and allosteric machines: new vistas and challenges for drug discovery","volume":"165","author":"Kenakin","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-394587-7.00006-3","article-title":"Application of receptor theory to allosteric modulation of receptors","volume":"115","author":"Hall","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2015.10.011_bib0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2015.10.011_bib0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tips.2014.04.007","article-title":"Biased ligands at G-protein-coupled receptors: promise and progress","volume":"35","author":"Violin","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0070","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705116","article-title":"Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity","volume":"138","author":"Gazi","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0075","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/mol.106.032722","article-title":"Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist\/inverse agonist for Gi1,Gi2, and Gi3","volume":"71","author":"Lane","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0080","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/jpet.107.120857","article-title":"Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi\/o,Gs, and G15","volume":"321","author":"Griffin","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2014.06.003","article-title":"What is pharmacological \u2018affinity\u2019: relevance to biased agonism and antagonism","volume":"35","author":"Kenakin","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0090","doi-asserted-by":"crossref","DOI":"10.1124\/mol.115.099770","article-title":"The effective application of biased signaling to new drug discovery","author":"Kenakin","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-2914-6_11","article-title":"The measurement of receptor signaling nias","volume":"1335","author":"Kenakin","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0100","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of \u03b2-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.10.011_bib0105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2015.10.011_bib0110","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.clinthera.2010.01.021","article-title":"Aripiprazole in schizophrenia and schizoaffective disorder: a review","volume":"32","author":"Stip","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2015.10.011_bib0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0006-3223(97)00030-9","article-title":"Antipsychotic properties of the partial dopamine agonist (\u2212)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in schizophrenia","volume":"43","author":"Lahti","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2015.10.011_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","article-title":"Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways","volume":"32","author":"Urban","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2015.10.011_bib0130","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2015.10.011_bib0135","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.10.011_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/\u03b2-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2015.10.011_bib0145","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2015.10.011_bib0150","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bcp.2015.10.011_bib0155","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/S0021-9258(18)53442-6","article-title":"A mutation-induced activated state of the beta 2-adrenergic receptor: extending the ternary complex model","volume":"268","author":"Samama","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.10.011_bib0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the beta2 adrenergic receptor\u2013Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0165","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.1150577","article-title":"High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor","volume":"318","author":"Cherezov","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.10.011_bib0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nature06325","article-title":"Crystal structure of the human beta2 adrenergic G-protein-coupled receptor","volume":"450","author":"Rasmussen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature14656","article-title":"Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser","volume":"523","author":"Kang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature09746","article-title":"The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor","volume":"469","author":"Warne","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0185","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"Chien","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.10.011_bib0190","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1241475","article-title":"Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex","volume":"341","author":"Tan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.10.011_bib0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature13083","article-title":"Structure of the human P2Y12 receptor in complex with an antithrombotic drug","volume":"509","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature11896","article-title":"Molecular signatures of G-protein-coupled receptors","volume":"494","author":"Venkatakrishnan","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2013.01.008","article-title":"The dynamic process of \u03b22-adrenergic receptor activation","volume":"152","author":"Nygaard","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2015.10.011_bib0210","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2015.04.043","article-title":"Structural insights into the dynamic process of \u03b22-adrenergic receptor signaling","volume":"161","author":"Manglik","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2015.10.011_bib0215","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.1215802","article-title":"Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR","volume":"335","author":"Liu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.10.011_bib0220","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1073\/pnas.151239698","article-title":"Single-molecule spectroscopy of the \u03b2(2) adrenergic receptor: observation of conformational substates in a membrane protein","volume":"98","author":"Peleg","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.10.011_bib0225","doi-asserted-by":"crossref","first-page":"22165","DOI":"10.1074\/jbc.M502352200","article-title":"Probing the \u03b22 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists","volume":"280","author":"Swaminath","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.10.011_bib0230","doi-asserted-by":"crossref","first-page":"24433","DOI":"10.1074\/jbc.C100162200","article-title":"Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor","volume":"276","author":"Ghanouni","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.10.011_bib0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/mol.54.2.435","article-title":"Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations","volume":"54","author":"Wiens","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0240","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/mol.111.075457","article-title":"Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations","volume":"81","author":"Fowler","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0245","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/S0021-9258(20)79672-9","article-title":"A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor","volume":"255","author":"De Lean","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.10.011_bib0250","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1073\/pnas.86.19.7321","article-title":"Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins","volume":"86","author":"Costa","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.10.011_bib0255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tips.2014.09.010","article-title":"What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling","volume":"35","author":"Onaran","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pnpbp.2011.08.007","article-title":"Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole","volume":"36","author":"Koener","year":"2012","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2015.10.011_bib0265","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1471-4892(01)00091-1","article-title":"Reporter-gene systems for the study of G-protein-coupled receptors","volume":"1","author":"Hill","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2009.04.065","article-title":"The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism","volume":"615","author":"Simon","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0275","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1124\/jpet.301.3.1166","article-title":"Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase","volume":"301","author":"Mottola","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0280","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1124\/jpet.301.3.1179","article-title":"Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs","volume":"301","author":"Kilts","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0285","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0290","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0022-3565(24)38226-6","article-title":"A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells","volume":"289","author":"Ehlert","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00210-008-0260-4","article-title":"On the analysis of ligand-directed signaling at G protein-coupled receptors","volume":"377","author":"Ehlert","year":"2008","journal-title":"Naunyn-Schmiedeberg Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0300","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/mol.108.051276","article-title":"Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors","volume":"75","author":"Tran","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0305","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/jpet.111.179309","article-title":"Analysis of agonism and inverse agonism in functional assays with constitutive activity: estimation of orthosteric ligand affinity constants for active and inactive receptor states","volume":"338","author":"Ehlert","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0310","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/mol.111.072801","article-title":"Quantifying ligand bias at seven-transmembrane receptors","volume":"80","author":"Rajagopal","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0315","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/mol.114.096503","article-title":"A novel method for analyzing extremely biased agonism at G protein-coupled receptors","volume":"87","author":"Stahl","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0320","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism Proc. R. Soc. Lond. B Biol. Sci","volume":"220","author":"Black","year":"1983","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0325","series-title":"The Mode of Action of Drugs on Cells","author":"Clark","year":"1933"},{"key":"10.1016\/j.bcp.2015.10.011_bib0330","first-page":"21","article-title":"The use of beta-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor\u2013agonist complexes","volume":"3","author":"Furchgott","year":"1966","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.bcp.2015.10.011_bib0335","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.1985.tb12941.x","article-title":"An operational model of pharmacological agonism: the effect of E\/[A] curve shape on agonist dissociation constant estimation","volume":"84","author":"Black","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1476-5381.1993.tb13799.x","article-title":"Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach","volume":"110","author":"Leff","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0345","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1087057111406548","article-title":"Understanding the effect of different assay formats on agonist parameters: a study using the micro-opioid receptor","volume":"16","author":"Nickolls","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bcp.2015.10.011_bib0350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-5193(89)80094-3","article-title":"Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?","volume":"140","author":"Leff","year":"1989","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0355","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"Kenakin","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2015.10.011_bib0360","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0365","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3954-c1","article-title":"Quantifying biased agonism: understanding the links between affinity and efficacy","volume":"12","author":"Rajagopal","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2015.10.011_bib0370","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3954-c2","article-title":"Measurements of ligand bias and functional affinity","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2015.10.011_bib0375","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/mol.112.080911","article-title":"Analysis of multiple histamine H4 receptor compound classes uncovers G\u03b1i protein- and \u03b2-arrestin2-biased ligands","volume":"82","author":"Nijmeijer","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0380","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tips.2009.06.007","article-title":"7TM receptor allostery: putting numbers to shapeshifting proteins","volume":"30","author":"Kenakin","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0385","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1021\/jm401318w","article-title":"A structure\u2013activity analysis of biased agonism at the dopamine D2 receptor","volume":"56","author":"Shonberg","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2015.10.011_bib0390","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1021\/jm500457x","article-title":"Structure\u2013activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D(2) receptor","volume":"57","author":"Szabo","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2015.10.011_bib0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/mol.110.068106","article-title":"Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor","volume":"79","author":"Tschammer","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0400","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/mol.113.088880","article-title":"Quantification of ligand bias for clinically relevant \u03b22-adrenergic receptor ligands: implications for drug taxonomy","volume":"85","author":"van der Westhuizen","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00210-014-1054-5","article-title":"Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the \u03b22-adrenoceptor","volume":"388","author":"Reinartz","year":"2015","journal-title":"Naunyn-Schmiedeberg Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0410","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.bjp.0707672","article-title":"Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors","volume":"153","author":"Strange","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0415","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/mol.109.061440","article-title":"Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity","volume":"77","author":"Strachan","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0420","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/jpet.114.220293","article-title":"Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways","volume":"352","author":"Brust","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0425","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0026-895X(25)11023-7","article-title":"Regulation of dopamine D2 receptors by sodium and pH","volume":"39","author":"Neve","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0430","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bjp.0706866","article-title":"Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor","volume":"149","author":"Lin","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0435","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1476-5381.2012.01901.x","article-title":"Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4","volume":"166","author":"Slack","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0440","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07139","article-title":"On the nature of partial agonism in the nicotinic receptor superfamily","volume":"454","author":"Lape","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.10.011_bib0445","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.65.4.986","article-title":"Temporal characteristics of camp response element-mediated gene transcription: requirement for sustained camp production","volume":"65","author":"Baker","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1098\/rspb.1961.0020","article-title":"A theory of drug action based on the rate of drug\u2013receptor combination","volume":"154","author":"Paton","year":"1961","journal-title":"Proc. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.bcp.2015.10.011_bib0455","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/mol.108.054452","article-title":"Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor","volume":"76","author":"Sykes","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0460","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/jpet.106.107375","article-title":"Determining the potency and molecular mechanism of action of insurmountable antagonists","volume":"319","author":"Kenakin","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.10.011_bib0465","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bph.12245","article-title":"Binding kinetics differentiates functional antagonism of orexin-2 receptor ligands","volume":"171","author":"Mould","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.10.011_bib0470","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1038\/ncomms9480","article-title":"Optodynamic simulation of beta-adrenergic receptor signalling","volume":"6","author":"Siuda","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215006656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215006656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:02:17Z","timestamp":1748664137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215006656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":94,"alternative-id":["S0006295215006656"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.10.011","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}